Oliver Luxxe Assets LLC Decreases Stock Position in Encompass Health Corporation $EHC

Oliver Luxxe Assets LLC decreased its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 12.0% during the third quarter, Holdings Channel.com reports. The firm owned 57,282 shares of the company’s stock after selling 7,820 shares during the period. Encompass Health accounts for about 1.2% of Oliver Luxxe Assets LLC’s portfolio, making the stock its 26th largest position. Oliver Luxxe Assets LLC’s holdings in Encompass Health were worth $7,276,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Royal Bank of Canada boosted its holdings in shares of Encompass Health by 21.5% during the 1st quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after purchasing an additional 15,677 shares during the last quarter. Millennium Management LLC increased its position in Encompass Health by 38.4% during the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after buying an additional 25,574 shares during the period. Goldman Sachs Group Inc. grew its holdings in shares of Encompass Health by 25.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,119,259 shares of the company’s stock worth $113,359,000 after acquiring an additional 224,477 shares during the period. Caxton Associates LLP acquired a new position in shares of Encompass Health in the 1st quarter valued at $259,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Encompass Health by 6.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 390,494 shares of the company’s stock worth $39,549,000 after buying an additional 22,896 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on EHC. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. UBS Group increased their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. Barclays lifted their target price on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Wall Street Zen cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $142.86.

Encompass Health Trading Down 2.0%

Shares of EHC opened at $102.89 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. Encompass Health Corporation has a 52-week low of $90.67 and a 52-week high of $127.99. The firm has a market cap of $10.35 billion, a price-to-earnings ratio of 19.45, a PEG ratio of 1.66 and a beta of 0.74. The business’s fifty day moving average is $110.79 and its 200-day moving average is $116.99.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The firm had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%. Equities analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s payout ratio is presently 14.37%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.